A new attenuated Mycobacterium bovis vaccine protects brushtail possums (Trichosurus vulpecula) against experimental tuberculosis infection

Vaccine

Volumn 25, Issue 24, 2007, Pages 4659-4664

  Collins, Desmond M ^a   de Lisle, Geoffrey W ^a   Aldwell, Frank E ^b   Buddle, Bryce M ^a  

^a AGRESEARCH   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Possums; Tuberculosis; Vaccine

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG; WAG 533 VACCINE;

AEROSOL; ARTICLE; BACTERIAL STRAIN; BRUSHTAIL POSSUM; COMPARATIVE STUDY; CONTROLLED STUDY; EXPERIMENTAL INFECTION; INOCULATION; MALE; MYCOBACTERIUM BOVIS; NEW ZEALAND; NONHUMAN; PRIORITY JOURNAL; PROTECTION; STATISTICAL SIGNIFICANCE; TRICHOSURUS; TRICHOSURUS VULPECULA; TUBERCULOSIS;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; BCG VACCINE; CELL PROLIFERATION; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; INJECTIONS, SUBCUTANEOUS; LEUKOCYTES, MONONUCLEAR; LIVER; LUNG; LYMPHOCYTES; MALE; MYCOBACTERIUM BOVIS; SPLEEN; TRICHOSURUS; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINES, ATTENUATED;

EID: 34248589896     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.014     Document Type: Article

References (19)

1. Grange J.M. Mycobacterium bovis infection in human beings. Tuberculosis 81 (2001) 71-77
2. Cosivi O., Grange J.M., Daborn C.J., Raviglione M.C., Fujikura T., Cousins D., et al. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis 4 (1998) 59-70
3. O'Reilly L.M., and Daborn C.J. The epidemiology of Mycobacterium bovis infection in animals and man: a review. Tubercle Lung Dis 76 Suppl 1 (1995) 1-46
4. de Lisle G.W., Bengis R.G., Schmitt S.M., and O'Brien D.J. Tuberculosis in free-ranging wildlife: detection, diagnosis and management. Rev Sci Tech 21 (2002) 317-334
5. Lesellier S., Palmer S., Dalley D.J., Dave D., Johnson L., Hewinson R.G., et al. The safety and immunogenicity of Bacillus Calmette-Guerin (BCG) vaccine in European badgers (Meles meles). Vet Immunol Immunopathol 112 (2006) 24-37
6. Gormley E., and Costello E. Tuberculosis and badgers: new approaches to diagnosis and control. J Appl Microbiol 94 Suppl. (2003) 80S-86S
7. Wedlock D.N., Aldwell F.E., Keen D., Skinner M.A., and Buddle B.M. Oral vaccination of brushtail possums (Trichosurus vulpecula) with BCG: immune responses, persistence of BCG in lymphoid organs and excretion in faeces. NZ Vet J 53 (2005) 301-306
8. Buddle B.M., Wedlock D.N., and Denis M. Progress in the development of tuberculosis vaccines for cattle and wildlife. Vet Microbiol 112 (2006) 191-200
9. de Lisle G.W., Wilson T., Collins D.M., and Buddle B.M. Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis. Infect Immunol 67 (1999) 2624-2626
10. Collins D.M., Wilson T., Campbell S., Buddle B.M., Wards B.J., Hotter G., et al. Production of avirulent mutants of Mycobacterium bovis with vaccine properties by the use of illegitimate recombination and screening of stationary phase cultures. Microbiology 148 (2002) 3019-3027
11. Hotter G.S., Wards B.J., Mouat P., Besra G.S., Gomes J., Singh M., et al. Transposon mutagenesis of Mb0100 at the PPE1-nrp locus in Mycobacterium bovis disrupts phthiocerol dimycocerosate (PDIM) and glycosylphenol-PDIM biosynthesis, producing an avirulent strain with vaccine properties at least equal to BCG. J Bacteriol 187 (2005) 2267-2277
12. Raman S., Puyang X., Cheng T.Y., Young D.C., Moody D.B., and Husson R.N. Mycobacterium tuberculosis SigM positively regulates Esx secreted protein and nonribosomal peptide synthetase genes and down regulates virulence-associated surface lipid synthesis. J Bacteriol 188 (2006) 8460-8468
13. Aldwell F.E., Keen D.L., Parlane N.A., Skinner M.A., de Lisle G.W., and Buddle B.M. Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums. Vaccine 22 (2003) 70-76
14. Kent P.T., and Kubica GP. Public health mycobacteriology, a guide for the level III laboratory (1985), US Department of Health and Human Service, Centres for Disease Control, Atlanta, GA
15. Buddle B.M., Aldwell F.E., Pfeffer A., and de Lisle G.W. Experimental Mycobacterium bovis infection in the brushtail possum (Trichosurus vulpecula): pathology, haematology and lymphocyte stimulation responses. Vet Microbiol 38 (1994) 241-254
16. Corner L.A., Norton S., Buddle B.M., and Morris R.S. The efficacy of bacille Calmette-Guerin vaccine in wild brushtail possums (Trichosurus vulpecula). Res Vet Sci 73 (2002) 145-152
17. Buddle B.M., Aldwell F.E., Keen D.L., Parlane N.A., Hamel K.L., and de Lisle G.W. Oral vaccination of brushtail possums with BCG: investigation into factors that may influence vaccine efficacy and determination of duration of protection. NZ Vet J 54 (2006) 224-230
18. Skinner M.A., Keen D.L., Parlane N.A., Yates G.F., and Buddle B.M. Increased protection against bovine tuberculosis in the brushtail possum (Trichosurus vulpecula) when BCG is administered with killed Mycobacterium vaccae. Tuberculosis 82 (2002) 15-22
19. Andersen P., and Doherty T.M. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3 (2005) 656-662